VEGFA and neoplasm: TMEM are responsible for vascular endothelial growth factor A (VEGFA)-driven transient vascular leakiness and tumor cell intravasation and predict distant metastatic disease in breast cancer patients (Harney et al., 2015, Rohan et al., 2014, Sparano et al., 2017).